Do STAT3 inhibitors have potential in the future for cancer therapy?
10.1080/13543784.2017.1351941
Saved in:
Main Authors: | Andrea Wong, Gautam Sethi, Boon-Cher Goh, Hirpara J.L., Pervaiz S., Eu J.Q. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Editorial |
Published: |
Taylor & Francis
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/141512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
by: Lee M., et al.
Published: (2020) -
Nanoparticles Targeting STATs in Cancer Therapy
by: Ashrafizadeh, M., et al.
Published: (2021) -
DO VALUERS IN SINGAPORE HAVE A FUTURE?
by: FOO SIONG GUAN
Published: (2019) -
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
by: Sikka, S., et al.
Published: (2014) -
Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide
by: Kang, J, et al.
Published: (2020)